# Almaral

> Almaral is a VC fund in Kaarina backing Medical Device, Health Diagnostics and Software. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Kaarina, Finland
- Total investments: 6
- Last investment: Aug 2025
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/almaral
- Website: https://almaral.eu/

Almaral is a VC fund in Kaarina focused on Medical Device and Health Diagnostics. Almaral provides risk management advice long-term strategy development budgeting operational function setup legal support early-stage sales and marketing function setup, and commercialization.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $832k–$2.9M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 3 | 50% |
| Health Diagnostics | 2 | 33% |
| Software | 1 | 17% |
| Health Care | 1 | 17% |
| Gamification | 1 | 17% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 50% |
| Convertible Note | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Marginum | Marginum is a university-based medical technology startup developing fluorescence-based tissue detection systems. The company’s data-driven solutions enable monitoring of tissues during cancer surgery and treatments. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum’smultidisciplinary team works in close cooperation with academic, clinical and industrial experts to ensure its technological solutions’ seamless clinical compatibility. | $2.9M | Seed | Aug 22, 2025 |  |
| Moncyte Health | Moncyte Health is developing a patented technology to optimize the treatment and prevention of cardiovascular disease. | $1.1M | Seed | Oct 08, 2024 |  |
| Fepod | Fepod Oy Ltd develops a point-of-care diagnostics platform for rapid blood concentration measurement of pain medicine and other markers. Using a mobile phone, portable reader, and disposable sensors, it delivers quick, accurate results in minutes, enabling timely treatment decisions in acute care settings. The company aims to be the #1 acute carePOC diagnostics platform by 2030. | $434.3K | Convertible Note | May 31, 2024 |  |
| Marginum | Marginum is a university-based medical technology startup developing fluorescence-based tissue detection systems. The company’s data-driven solutions enable monitoring of tissues during cancer surgery and treatments. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum’smultidisciplinary team works in close cooperation with academic, clinical and industrial experts to ensure its technological solutions’ seamless clinical compatibility. | $1.1M | Seed | Nov 10, 2023 |  |
| Seppo | Lentava Liitutaulu (a.k.a. Seppo) is a Finnish start-up that is specialised in game-based-learning. It has created an interactive platform called Seppo, which allows users to take full advantage of mobile technology and magic of games in corporate training, strategy communication, ESG plan implementation, change management initiatives and beyond.Gamified solutions are versatile and rich – much more than simple quizzes – and encourages the players towards deep analysis, collaboration and self-reflection. The game environment can be e.g. 360 degree picture, 3D world or authentic environment. All this can be done without a single line of code.The solution is powered with artificial intelligence that helps users turn their training or strategy material into an engaging game literally in minutes. Seppo comes with large Content Library of ready made games. The main business model is automated recurring SaaS with ARR of 1 MEUR. | $1.2M | Venture - Series Unknown | Nov 02, 2022 |  |
| Fepod | Fepod Oy Ltd develops a point-of-care diagnostics platform for rapid blood concentration measurement of pain medicine and other markers. Using a mobile phone, portable reader, and disposable sensors, it delivers quick, accurate results in minutes, enabling timely treatment decisions in acute care settings. The company aims to be the #1 acute carePOC diagnostics platform by 2030. | $831.8K | Seed | May 15, 2022 |  |

6 of 6 investments shown.

## Co-investors
- [Nostetta Ventures](https://shizune.co/investors/profile/nostetta-ventures) — VC Fund, 2 deals together
- [Redstone.VC](https://shizune.co/investors/profile/redstone-digital-gmbh) — VC Fund, 2 deals together
- [Athensmed](https://shizune.co/investors/profile/athensmed) — VC Fund, 1 deal together
- [Dealia](https://shizune.co/investors/profile/dealia) — VC Fund, 1 deal together
- [Inventure](https://shizune.co/investors/profile/inventure-oy) — VC Fund, 1 deal together
- [Liquido.VC](https://shizune.co/investors/profile/liquido-vc) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Reach Capital](https://shizune.co/investors/profile/reach-capital) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [GSV Ventures](https://shizune.co/investors/profile/gsv-acceleration) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund
- [Lifeline Ventures](https://shizune.co/investors/profile/lifeline-ventures) — VC Fund
- [Tesi](https://shizune.co/investors/profile/tesi) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in Finland](https://shizune.co/investors/health-care-vc-funds-finland)
- [Medical Device VC Funds in Finland](https://shizune.co/investors/medical-device-vc-funds-finland)
- [Health Care Investors in Finland](https://shizune.co/investors/health-care-investors-finland)
- [EdTech VC Funds in Finland](https://shizune.co/investors/edtech-vc-funds-finland)
- [Education Investors in Finland](https://shizune.co/investors/education-investors-finland)
- [Education VC Funds in Finland](https://shizune.co/investors/education-vc-funds-finland)

## FAQ

### What does Almaral invest in?

Almaral invests primarily in Medical Device, Health Diagnostics and Software startups, most often at Seed and Convertible Note stage. Most of the 6 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Almaral's check size?

Almaral typically joins rounds of $832k–$2.9M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Almaral participates in.

### When did Almaral last invest?

The most recent investment recorded for Almaral closed in Aug 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co